(Q72490144)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6115335%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

title

Adaptive changes in catecholamine receptors in the central nervous system (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6115335%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

main subject

nervous system

0 references

physiological adaptation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6115335

8 August 2023

author name string

T. Reisine

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6115335

8 August 2023

language of work or name

English

0 references

publication date

1 January 1981

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6115335%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

27 October 2019

https://api.elsevier.com/content/article/PII:0306452281902219?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

https://api.elsevier.com/content/article/PII:0306452281902219?httpAccept=text/plain

8 August 2023

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

8 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6115335%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6115335%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

page(s)

1471-1502

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6115335%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6115335%20AND%20SRC:MED&resulttype=core&format=json

A study of the adrenotropic receptors

27 October 2019

cites work

3

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Direct identification and characterisation of β-adrenergic receptors in rat brain

8 August 2023

4

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Amantadine reduces haloperidol-induced dopamine receptor hypersensitivity in the striatum

8 August 2023

5

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Development of β-adrenergic receptor subsensitivity by antidepressants

8 August 2023

6

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Effect of electroconvulsive shock on monoaminergic receptor binding sites in rat brain

8 August 2023

9

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

A functional basis for classification of α-adrenergic receptors

8 August 2023

10

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Dopamine: spontaneous and drug-induced release from the caudate nucleus in the cat.

8 August 2023

11

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Effects of dopamine agonists on neurones in the caudate nucleus and cerebral cortex of cats chronically treated with neuroleptics

8 August 2023

12

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Endorphins: Profound Behavioral Effects in Rats Suggest New Etiological Factors in Mental Illness

8 August 2023

13

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Tritiated imipramine binding sites are decreased in platelets of untreated depressed patients

8 August 2023

14

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes

8 August 2023

17

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Antischizophrenic drugs: chronic treatment elevates dopamine receptor binding in brain

8 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Dopamine receptor binding in the corpus striatum of mammalian brain

8 August 2023

19

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

8 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Repeated tricyclics induce a progressive dopamine autoreceptor subsensitivity independent of daily drug treatment

8 August 2023

23

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Electroconvulsive shock: progressive dopamine autoreceptor subsensitivity independent of repeated treatment

8 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

A biochemical study of receptor internalization during beta-adrenergic receptor desensitization in frog erythrocytes

8 August 2023

26

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Antipsychotic drugs stimulate prolactin release

8 August 2023

27

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs

8 August 2023

28

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Characterization of a dopamine-sensitive adenylate cyclase in the rat caudate nucleus

8 August 2023

29

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

The development of cortical β-adrenoceptor subsensitivity in the rat by chronic treatment with trazodone, doxepin and mianserine

8 August 2023

30

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Striatal dopamine receptors become supersensitive while rats are given trifluoperazine for six months

8 August 2023

31

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic

8 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration

8 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Excitation-mediating and inhibition-mediating dopamine-receptors: A new concept towards a better understanding of electrophysiological, biochemical, pharmacological, functional and clinical data

8 August 2023

34

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

8 August 2023

35

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity

8 August 2023

36

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

3H-N-n-propylnorapomorphine: A novel agonist ligand for central dopamine receptors

8 August 2023

37

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding

8 August 2023

38

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Presynaptic Alpha-Receptor Subsensitivity After Long-Term Antidepressant Treatment

8 August 2023

39

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Dopaminergic mechanisms in schizophrenia: The antipsychotic effect and the disease process

8 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Effects of estrogen and progesterone on plasma gonadotropins and on catecholamine levels and turnover in discrete brain regions of ovariectomized rats

8 August 2023

41

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin.

8 August 2023

45

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

The resolution of dopamine and β1- and β2-adrenergic-sensitive adenylate cyclase activities in homogenates of cat cerebellum, hippocampus and cerebral cortex

8 August 2023

49

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

The striatum and substantia nigra: A commentary on their relationships

8 August 2023

50

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Effects of apomorphine and clonidine on rat plasma growth hormone after pretreatment with reserpine and electroconvulsive shocks

8 August 2023

51

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Possible actions of opiates upon synapses

8 August 2023

52

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Effect of estrogen on changes in the activity of striatal cholinergic neurons induced by DA drugs

8 August 2023

53

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Enhanced sensitivity of caudate neurones to microiontophoretic injections of dopamine in 6-hydroxydopamine treated cats.

8 August 2023

54

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Biochemical demonstration of dopaminergic receptors in rat and human brain using [3H]spiroperidol

8 August 2023

55

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Behavioral effects of dopamine and p-hydroxyamphetamine injected into corpus striatum of rats

8 August 2023

56

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

INHIBITION OF UPTAKE OF TRITIATED-NORADRENALINE IN THE INTACT RAT BRAIN BY IMIPRAMINE AND STRUCTURALLY RELATED COMPOUNDS.

8 August 2023

58

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Alpha-noradrenergic receptor binding in mammalian brain: Differential labeling of agonist and antagonist states

8 August 2023

61

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

β-Adrenergic Receptors in Aged Rat Brain: Reduced Number and Capacity of Pineal Gland to Develop Supersensitivity

8 August 2023

62

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

8 August 2023

Aging and hormones

64

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Naloxone-induced reversal of schizophrenic hallucinations

8 August 2023

65

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Neuronal degeneration in rat brain induced by 6-hydroxydopamine; a histological and biochemical study.

8 August 2023

67

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Electroconvulsive shock: Sustained decrease in norepinephrine uptake affinity in a reserpine model of depression

8 August 2023

68

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Enzymatic methylation of phosphatidylethanolamine increases erythrocyte membrane fluidity

8 August 2023

70

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Phospholipid Methylation and Biological Signal Transmission

8 August 2023

72

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Studies on norepinephrine-containing afferents to Purkinje cells of rat cerebellum. II. Sensitivity of Purkinje cells to norepinephrine and related substances administered by microiontophoresis.

8 August 2023

75

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Depression by reserpine of the noradrenaline concentration in the hypothalamus of the cat.

8 August 2023

76

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Dopamine (3-hydroxytyramine) and brain function

8 August 2023

77

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Psychopharmacological implications of dopamine and dopamine antagonists: a critical evaluation of current evidence

8 August 2023

78

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Acute and chronic amphetamine treatments modulate striatal dopamine receptor binding sites

8 August 2023

79

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Hypophysectomy prevents the striatal dopamine receptor supersensitivity produced by chronic haloperidol treatment

8 August 2023

80

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Estrogen treatment enhances dopamine receptor sensitivity in the rat striatum

8 August 2023

81

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Increased dopamine receptor sensitivity after estrogen treatment using the rat rotation model

8 August 2023

82

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Carazolol, an extremely potent β-adrenergic blocker: Binding to β-receptors in brain membranes

8 August 2023

83

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Further evidence for the existence of multiple receptors for dopamine in the central nervous system

8 August 2023

85

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Negative naloxone effects in schizophrenic patients

8 August 2023

86

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Effects of desipramine and yohimbine on α2- and β-adrenoreceptor sensitivity

8 August 2023

89

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Multiple receptors for dopamine

8 August 2023

91

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Down regulation of dihydroalprenolol and imipramine binding sites in brain of rats repeatedly treated with imipramine

8 August 2023

95

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders.

8 August 2023

96

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Pharmacological actions of 6-hydroxydopamine

8 August 2023

98

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

The treatment of perceptual disturbances in schizophrenia with naloxone hydrochloride

8 August 2023

99

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Domperidone, a specific in vitro dopamine antagonist, devoid of in vivo central dopaminergic activity

8 August 2023

100

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

The tricyclic antidepressants—Inhibition of norepinephrine uptake as related to potentiation of norepinephrine and clinical efficacy

8 August 2023

101

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Narcotic dependence, narcotic action and dopamine receptors

8 August 2023

102

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Differentiation of Receptor Systems activated by Sympathomimetic Amines

8 August 2023

103

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Presynaptic regulation of catecholamine release

8 August 2023

104

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

High-affinity [3H]imipramine binding in rat hypothalamus: association with uptake of serotonin but not of norepinephrine

8 August 2023

106

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Chronic treatment with metoclopramide induces behavioral supersensitivity to apomorphine and enhances specific binding of 3H-spiroperidol to rat striata

8 August 2023

107

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Receptor basis for dopaminergic supersensitivity in Parkinson's disease.

8 August 2023

108

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains.

8 August 2023

109

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Unitary dopaminergic receptor composed of cooperatively linked agonist and antagonist sub-unit binding sites

8 August 2023

111

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites

8 August 2023

112

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Spiperone: a ligand of choice for neuroleptic receptors. 1. Kinetics and characteristics of in vitro binding

8 August 2023

113

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Differential distribution of opiate and neuroleptic receptors and dopamine-sensitive adenylate cyclase in rat brain

8 August 2023

115

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Serotonergic component of neuroleptic receptors

8 August 2023

116

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Dopamine agonists reverse the elevated 3H-neuroleptic binding in neuroleptic-pretreated rats

8 August 2023

118

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Effects of chronic desipramine treatment on rat brain noradrenergic responses to α-adrenergic drugs

8 August 2023

119

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Effect of aging on neurotransmitter receptor binding in rat and human brain

8 August 2023

120

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

beta-Adrenergic regulation of alpha 2-adrenergic receptors in the central nervous system

8 August 2023

121

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Differential effects of antidepressant treatment on brain monoaminergic receptors

8 August 2023

122

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

The effect of repeated administration of antidepressant drugs on the responsiveness of rats to catecholamine agonists

8 August 2023

124

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Chronic treatment with antidepressant drugs: Potentiation of apomorphine-induced aggressive behaviour in rats

8 August 2023

125

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Characterization of 3H-domperidone binding on striatal dopamine receptors.

8 August 2023

126

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

The dopamine hypothesis of schizophrenia: a review

8 August 2023

127

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Chronic antidepressant treatment enhances alpha-adrenergic and serotonergic responses in the facial nucleus

8 August 2023

128

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Perceptual capacity, functions of the corpus striatum and schizophrenia

8 August 2023

129

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Differential regulation of the α2-adrenergic receptor by Na+ and guanine nucleotides

8 August 2023

130

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Effects of dopamine-like drugs on rat striatal adenyl cyclase have implications for CNS dopamine receptor topography.

8 August 2023

133

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

β 1 - and β 2 -Adrenergic Receptors in Rat Cerebral Cortex Are Independently Regulated

8 August 2023

134

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Classification and quantitation of β-adrenergic receptor subtypes

8 August 2023

136

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Enhancement of dopamine-stimulated adenylate cyclase activity in rat caudate after lesions in substantia nigra: evidence for denervation supersensitivity

8 August 2023

137

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Subsensitivity of the norepinephrine receptor-coupled adenylate cyclase system in brain: Effects of Nisoxetine versus fluoxetine

8 August 2023

138

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Brain neurotransmitter receptors after long-term haloperidol: Dopamine, acetylcholine, serotonin, α-noradrenergic and naloxone receptors

8 August 2023

139

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Direct evidence for presynaptic and postsynaptic dopamine receptors in brain

8 August 2023

141

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Selective blockade of excitatory caudate responses to nigral stimulation by microiontophoretic application of dopamine antagonists

8 August 2023

143

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

A quantitative analysis of the excitatory and depressant effects of dopamine on the firing of caudatal neurons: electrophysiological support for the existence of two distinct dopamine-sensitive receptors

8 August 2023

144

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Reduced sensitivity of neurons to noradrenaline after chronic treatment with antidepressant drugs

8 August 2023

145

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Dopamine-mediated behaviour and 3H-spiperone binding to striatal membranes in rats after nine months haloperidol administration

8 August 2023

147

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Increased dopamine-receptor sensitivity in schizophrenia

8 August 2023

148

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Electroconvulsive shock treatment decreases β-adrenergic receptor sensitivity in rat brain

8 August 2023

149

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Inhibition of neuronal uptake reduces the presynaptic effects of clonidine but not of α-methylnoradrenaline on the stimulation-evoked release of 3H-noradrenaline from rat occipital cortex slices

8 August 2023

150

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Long-Term Treatment with Lithium Prevents the Development of Dopamine Receptor Supersensitivity

8 August 2023

151

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Axanol proliferation following lesions of cerebellar peduncles. A combined fluorescence microscopic and radioautographic study.

8 August 2023

152

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Short-term surgical denervation increases 3H-clonidine binding in rat salivary gland

8 August 2023

153

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Ontogeny of beta 1- and beta 2-adrenergic receptors in rat cerebellum and cerebral cortex.

8 August 2023

154

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra

8 August 2023

156

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Subsensitivity of the rat striatal dopaminergic system after treatment with bromocriptine: effects on [3H]spiperone binding and dopamine-stimulated cyclic AMP formation

8 August 2023

157

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Specific tricyclic antidepressant binding sites in rat brain characterised by high-affinity 3H-imipramine binding

8 August 2023

158

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Specific tricyclic antidepressant binding sites in rat brain

8 August 2023

159

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Specific labelling of postsynaptic ?1 adrenoceptors in rat heart ventricle by 3H-WB 4101

8 August 2023

160

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Localization of dopamine receptors in rat brain

8 August 2023

161

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Pre- and postsynaptic neurochemical alterations in Alzheimer's disease

8 August 2023

163

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Effects of combined administration of amphetamine and iprindole on brain adrenergic receptors

8 August 2023

164

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

The content of 5-hydroxyindoleacetic acid and homovanillic acid in the cerebrospinal fluid of patients with acute schizophrenia

8 August 2023

165

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Effect of iprindole on norepinephrine turnover and transport

8 August 2023

168

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

3HPara-amino-clonidine: A novel ligand which binds with high affinity to α-adrenergic receptors

8 August 2023

169

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Desmethylimipramine-induced decrease in β-adrenergic receptor binding in rat cerebral cortex

8 August 2023

170

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Effect of clonidine on utilization and potassium-evoked release of adrenaline in rat brain areas

8 August 2023

171

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

The catecholamine hypothesis of affective disorders: a review of supporting evidence

8 August 2023

172

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Biogenic Amines and Emotion

8 August 2023

173

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Modulation of receptor mechanisms in the CNS: Hyper-and hyposensitivity to catecholamines

8 August 2023

175

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Brain receptors for antipsychotic drugs and dopamine: direct binding assays

8 August 2023

176

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Antipsychotic drug doses and neuroleptic/dopamine receptors

8 August 2023

178

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

The action of norepinephrine in the rat hippocampus. I. Iontophoretic studies.

8 August 2023

179

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

The effect of psychoactive drugs on beta-adrenergic receptor binding sites in rat brain

8 August 2023

180

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Electrophysiological evidence for involvement of cyclic adenosine monophosphate in dopamine responses of caudate neurons

8 August 2023

182

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Cyclic adenosine monophosphate and norepinephrine: effects on transmembrane properties of cerebellar Purkinje cells.

8 August 2023

183

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

The effects of acute and chronic haloperidol treatment on spontaneously firing neurons in the caudate nucleus of the rat

8 August 2023

185

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Binding of α- and β-adrenergic ligands to cerebral cortical membranes: Effect of 6-hydroxydopamine treatment and relationship to the responsiveness of cyclic AMP-generating systems in two rat strains

8 August 2023

186

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

3H-apomorphine labels both dopamine postsynaptic receptors and autoreceptors

8 August 2023

188

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

β-Adrenergic Receptor Involvement in 6-Hydroxydopamine-Induced Supersensitivity in Rat Cerebral Cortex

8 August 2023

189

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

beta-Adrenergic receptors in rat brain

8 August 2023

190

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Supersensitivity in rat cerebral cortex: pre- and postsynaptic effects of 6-hydroxydopamine at noradrenergic synapses

8 August 2023

191

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Phospholipid Methylation Unmasks Cryptic β-Adrenergic Receptors in Rat Reticulocytes

8 August 2023

192

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Functional Aspects of the Norepinephrine Receptor Coupled Adenylate Cyclase System in the Limbic Forebrain and its Modification by Drugs which Precipitate or Alleviate Depression: Molecular Approaches to an Understanding of Affective Disorders

8 August 2023

195

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Mode of action of antidepressant drugs

8 August 2023

196

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Feedback Inhibition of Brain Noradrenaline Neurons by Tricyclic Antidepressants: α-Receptor Mediation

8 August 2023

197

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Electrophysiological evidence for the action of light on the pineal gland in the rat

8 August 2023

200

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Increased CSF levels of endorphines in chronic psychosis

8 August 2023

201

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Evidence for loss of brain [3H]spiroperidil and [3H]ADTN binding sites in rabbit brain with aging

8 August 2023

203

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Selective labelling of different dopamine receptors by a new agonist 3H-ligand: 3H-N-propylnorapomorphine

8 August 2023

204

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

6-hydroxy-dopamine induced degeneration of central monoamine neurons

8 August 2023

206

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.

8 August 2023

207

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Dopaminergic supersensitivity in the striatum

8 August 2023

209

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Prazosin: differential affinities for two populations of α-noradrenergic receptor binding sites

8 August 2023

212

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

In vitro modulation of CNS β-receptor number by antidepressants and β-agonists

8 August 2023

214

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Differential supersensitivity of β-receptor subtypes in rat cortex and cerebellum after central noradrenergic denervation

8 August 2023

218

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Distinct α-noradrenergic receptors differentiated by binding and physiological relationships

8 August 2023

220

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Characterization and differential in vivo regulation of brain adrenergic receptor subtypes

8 August 2023

221

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Effects of 6-hydroxydopamine on catecholamine containing neurones in the rat brain

8 August 2023

222

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Improvement of Schizophrenic Patients Treated With Des-Tyr1]-γ-endorphin (DTγE)

8 August 2023

225

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Action of various antidepressant treatments reduces reactivity of noradrenergic cyclic AMP-generating system in limbic forebrain

8 August 2023

227

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Apomorphine-induced rotation in the unilateral 6-OHDA-lesioned rat: relationship to changes in striatal adenylate cyclase activity and 3H-spiperone binding

8 August 2023

228

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Neuroleptic treatment for a substantial proportion of adult life: behavioural sequelae of 9 months haloperidol administration

8 August 2023

229

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

beta-Adrenergic receptor regulation by agonists and membrane depolarization in rat brain slices

8 August 2023

230

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Enhanced sensitivity of amygdaloid neurons to serotonin and norepinephrine after chronic antidepressant treatment

8 August 2023

231

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Effects of Naloxone on Schizophrenia: Reduction in Hallucinations in a Subpopulation of Subjects

8 August 2023

232

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

dl-N-methyl-3-(o-methoxyphenoxy)-3-phenylpropylamine hydrochloride, Lilly 94939, a potent inhibitor for uptake of norepinephrine into rat brain synaptosomes and heart

8 August 2023

235

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

α-Adrenergic receptors modulate β-receptor affinity in rat kidney membranes

8 August 2023

236

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

Supersensitivity of caudate neurones after repeated administration of haloperidol

8 August 2023

238

1 reference

https://api.crossref.org/works/10.1016/0306-4522(81)90221-9

8 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6115335%20AND%20SRC:MED&resulttype=core&format=json

27 October 2019

1 reference